Teva to sell Allergan's generics unit in Ireland Teva Pharmaceutical Industries is to sell Allergan's generics business in the UK and Ireland to India's Intas Pharmaceuticals for £603m. Business • 06 Oct 16
Teva to sell Allergan's generics unit in Ireland Teva Pharmaceutical Industries is to sell Allergan's generics business in the UK and Ireland to India's Intas Pharmaceuticals for £603m. Business • 06 Oct 16
Pfizer abandons plan to split into two companies US drugmaker Pfizer, which has been considering a split into two companies for more than two years, said it will not do so because the move would not create any shareholder value. Business • 26 Sep 16
Pfizer abandons plan to split into two companies US drugmaker Pfizer, which has been considering a split into two companies for more than two years, said it will not do so because the move would not create any shareholder value. Business • 26 Sep 16
Pfizer quarterly earnings beat forecasts Pfizer has today reported second-quarter earnings which were slightly ahead of forecasts. Business • 30 Jul 13
Pfizer quarterly earnings beat forecasts Pfizer has today reported second-quarter earnings which were slightly ahead of forecasts. Business • 30 Jul 13
DCC in deal to buy UK's Kent Pharma Business support services group DCC has announced a deal to buy Kent Pharmaceuticals Holdings Limited for an enterprise value of €71.2m. Business • 20 Dec 12
DCC in deal to buy UK's Kent Pharma Business support services group DCC has announced a deal to buy Kent Pharmaceuticals Holdings Limited for an enterprise value of €71.2m. Business • 20 Dec 12
